Skip to content
  • KOSPI 2556.61 -8.81 -0.34%
  • KOSDAQ 717.24 -9.22 -1.27%
  • KOSPI200 338.74 -0.32 -0.09%
  • USD/KRW 1438 1.00 -0.07%
View Market Snapshot
Bio & Pharma

Seegene's COVID-19 diagnostic product wins Product of the Year Award

The S.Korean diagnostic kit maker has developed Allplex SARS-CoV-2 Assay which detects 4 different target genes

By Dec 16, 2022 (Gmt+09:00)

1 Min read

Seegene's COVID-19 diagnostic product wins Product of the Year Award 

Seegene Inc. said on Friday that its COVID-19 diagnostic product Allplex SARS-CoV-2 Assay received the Product of the Year Award at the BioSpectrum Asia Excellence Awards on Dec 2.

BioSpectrum Asia is a media platform and market research firm that covers the pharmaceutical and biotech industries in the region.

 "We will contribute to the healthy life of mankind by strengthening R&D to enable faster and more accurate diagnosis of infectious diseases and genetic diseases, and widening the range of molecular diagnostics by producing excellent products," said Seegene CEO Chun Jong-Yoon.

"As a global leader in molecular diagnostics, we will continue to monitor and respond to future pandemics," he added.

In addition, Lunit, a Seoul-based medical AI company, received the Startup of the Year award.

Write to Jeong Min Nam at peux@hankyung.com
More to Read
Comment 0
0/300